4 completed. 3 Phase 3, 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
Follow Alogliptin and Metformin: new trials by email Literature Review of Alogliptin and Metformin trials Research Report on Alogliptin and Metformin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Alogliptin on Pulmonary Function in Obese Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy Alogliptin and Metformin - Diabetes Mellitus, Type 2 | Not applicable | Completed | Fourth People's Hospital of Shenyang | 81 | 2014-05-01 | 2016-06-14 |
| Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan Alogliptin and glimepiride, Alogliptin and metformin - Type 2 Diabetes Mellitus | Phase 2 / Phase 3 | Completed | Takeda | 576 | 2009-01-01 | 2012-08-16 |
| Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in Japan Alogliptin and metformin, Metformin - Type 2 Diabetes Mellitus | Phase 2 / Phase 3 | Completed | Takeda | 288 | 2008-08-01 | 2012-02-03 |
| Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus Alogliptin and metformin, Metformin - Diabetes Mellitus | Phase 3 | Completed | Takeda | 527 | 2006-03-01 | 2012-02-03 |
Diabetes Mellitus, Type 2 (4) · Diabetes Mellitus (3) · Dyslipidemias (1) · Glucose Metabolism Disorders (1)
Takeda (3) · Fourth People's Hospital of Shenyang (1)
Argentina (1) · Australia (1) · Brazil (1) · Chile (1) · Czechia (1) · Germany (1) · Guatemala (1) · Hungary (1) · India (1) · Mexico (1) · Netherlands (1) · New Zealand (1) · Peru (1) · Poland (1) · South Africa (1)
PMID 19125992, PMID 19793357, PMID 24843617
2005 (1)